Literature DB >> 2530357

In vitro packaging of bacteriophage phi 29 DNA restriction fragments and the role of the terminal protein gp3.

S Grimes1, D Anderson.   

Abstract

Restriction fragments of bacteriophage phi 29 DNA-gp3 (DNA-gene product 3 complex) were packaged in a completely defined in vitro system that included purified proheads, the DNA packaging protein gp16 and ATP. Both left and right end DNA-gp3 fragments were packaged in this system, in contrast to the oriented and selective packaging of left end DNA-gp3 fragments in extracts; left ends could be packaged quantitatively in the defined system, while the packaging efficiency of right ends was generally about threefold lower. In addition, certain internal (non-end) DNA fragments were packaged at efficiencies of about 10% to 15%. Digestion of the gp3 with trypsin or proteinase K reduced the packaging of whole-length DNA by a factor of 2 or 4, respectively, and removal of the gp3 from whole-length DNA or end fragments with piperidine reduced packaging to the level of internal fragments. Though the terminal protein gp3 was non-essential for DNA translocation in the defined system, it stimulated packaging of left and right end fragments, and stabilized packaging of the left end. The packaging of end and internal DNA fragments of the related phage M2Y into phi 29 proheads was similar to that of phi 29 DNA fragments, and certain fragments of lambda DNA were packaged at the efficiency of the internal phi 29 DNA fragments. Selective packaging of DNA-gp3 left ends was restored by the addition of bacterial cell extracts or glycerol to the defined system, and these packaging conditions discriminated between phi 29 and M2Y DNAs that have distinct terminal proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530357     DOI: 10.1016/0022-2836(89)90172-1

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  DNA packaging motor assembly intermediate of bacteriophage phi29.

Authors:  Jaya S Koti; Marc C Morais; Raj Rajagopal; Barbara A L Owen; Cynthia T McMurray; Dwight L Anderson
Journal:  J Mol Biol       Date:  2008-04-20       Impact factor: 5.469

3.  Counting of six pRNAs of phi29 DNA-packaging motor with customized single-molecule dual-view system.

Authors:  Dan Shu; Hui Zhang; Jiashun Jin; Peixuan Guo
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

4.  Isolation and characterization of a generalized transducing phage for Xanthomonas campestris pv. campestris.

Authors:  B D Weiss; M A Capage; M Kessel; S A Benson
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

5.  Purification and functional characterization of p16, the ATPase of the bacteriophage Phi29 packaging machinery.

Authors:  B Ibarra; J M Valpuesta; J L Carrascosa
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

Review 6.  Single-molecule studies of viral DNA packaging.

Authors:  Yann R Chemla; Douglas E Smith
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 7.  Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy.

Authors:  Tae Jin Lee; Chad Schwartz; Peixuan Guo
Journal:  Ann Biomed Eng       Date:  2009-06-04       Impact factor: 3.934

8.  In vitro assembly of infectious virions of double-stranded DNA phage phi 29 from cloned gene products and synthetic nucleic acids.

Authors:  C S Lee; P Guo
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Role of the CCA bulge of prohead RNA of bacteriophage ø29 in DNA packaging.

Authors:  Wei Zhao; Marc C Morais; Dwight L Anderson; Paul J Jardine; Shelley Grimes
Journal:  J Mol Biol       Date:  2008-08-29       Impact factor: 5.469

10.  Multifunctional roles of a bacteriophage phi 29 morphogenetic factor in assembly and infection.

Authors:  Daniel N Cohen; Stephen E Erickson; Ye Xiang; Michael G Rossmann; Dwight L Anderson
Journal:  J Mol Biol       Date:  2008-03-07       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.